Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Staying healthy

From short-term health care bets to long-term energy plays, and the swings of the cannabis market, small-cap investors have had their hands full keeping up with the markets in 2023. A recent merger among top names in cannabis hit the health care market hard this...
Jonathon Brown | April 13, 2023 |

The future of the textile marketplace

Countries manufacturing textiles will likely acquire a healthy dose of revenue into their economy. According to fiber2fashion.com , the population is increasing to 9.5 billion, with the global apparel market reaching over $2 trillion by 2025. Given the massive gr...
Brieanna McCutcheon | April 28, 2023 |

SunPower (SPWRA): Retreating into familiar territory

Last week, SunPower Corporation ( NASDAQ: SPWRA , Stock Forum ) updated its 2011 guidance, predicting that ex-items earnings per share would range between $1.75 and $2.05. Revenue for the upcoming fiscal year is predicted to arrive between $2.65 billion and $2.85 billion....
Andrea Kramer | October 28, 2012 |

Nov 23rd 2019, Crypto Chartbook – Why markets work

Why markets work We as humans are fooled by a brain that functions on comparison. However, based on the true principle, every moment is unique and we expand with every time increment into an absolutely new future (big bang theory). We would be overwhelmed by the vastness o...
Korbinian Koller | November 26, 2019 |

Feb 7th 2020, Crypto Chartbook – The trend is your friend

The trend is your friend That might be an overused term but it is so very true! After “compound interest” (Albert Einstein: “Compound interest is the 8th wonder of the world”), a directional market is the strongest free e...
Korbinian Koller | February 10, 2020 |

VIDEO: Mine Gold Without Mining? ELY Gold talks Nevada

Want to mine Gold without mining? - Royalty companies receive streams of cash from a business in exchange for cash upfront or land usage — it is relatively easy to understand. They also often pay healthy dividends; which income investors can appreciate. Developing a...
Stockhouse Media | August 28, 2019 |

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...
Chris Ciovacco | December 3, 2019 |

The SUPER-State Cannabis Company that’s on the Move

(Click image to play podcast) It’s been a busy and productive last few months for the cannabis industry’s only true super-state operator. And as reported by Stockhouse back in August , this Company continues to make big waves ...
Dave Jackson | October 28, 2020 |

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Shares of Moderna Inc. traded up double-digits today as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. This morning clinical-stage biotechnology company Mode...
Streetwise Reports | September 13, 2019 |

The S&P 500 Bull Is Slowly Climbing the Wall of Worry

You may ask whether the S&P 500 rebound has stalled, or is that just a healthy consolidation – to which I would reply that the market is merely digesting gains from its sharp upside reversal. In the battle of narratives, the corona second wave fears still play second fiddle to...
Monica Kingsley | June 19, 2020 |
1 2 3 4 5 6 7 8 9 10 ...